Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

SVB Leerink Maintains Outperform on HOOKIPA Pharma, Lowers Price Target to $3

SVB Leerink analyst Andrew Berens maintains HOOKIPA Pharma (NASDAQ:HOOK) with a Outperform and lowers the price target from $4 to $3.
byBenzinga Newsdesk
August 11, 2022
1 minute read
Total
0
Shares
0
0
0
0
0
0

SVB Leerink analyst Andrew Berens maintains HOOKIPA Pharma (NASDAQ:HOOK) with a Outperform and lowers the price target from $4 to $3.

 
Total
0
Shares
Share 0
Tweet 0
Share 0
Share 0
Share 0
Share 0
Related Posts